Global Alliance for TB Drug Development begins phase I trial of TBI-223 in healthy subjects Jan. 18, 2019
Novartis begins first-in-human trial of NJH-395 in non-breast HER2-positive advanced malignancies Jan. 18, 2019
Patient enrollment ongoing in Roche's phase III study of RO-7234292 in Huntington's disease Jan. 18, 2019
RSS